Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual-Acting Angiotensin Receptor-Neprilysin Inhibitor (ARNi)-Reference-Cited by-同舟云学术

Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual-Acting Angiotensin Receptor-Neprilysin Inhibitor (ARNi)

Published:2010-04 Issue:4 Volume:50 Page:401-414
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Gu Jessie,Noe Adele,Chandra Priya,Al-Fayoumi Suliman,Ligueros-Saylan Monica,Sarangapani Ramesh,Maahs Suzanne,Ksander Gary,Rigel Dean F.,Jeng Arco Y.,Lin Tsu-Han,Zheng Weiyi,Dole William P.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1177/0091270009343932/fullpdf

Reference20 articles.

1. Natriuretic peptides and therapeutic applications;Lee;Heart Fail Rev,2007

2. Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases;Rubattu;Am J Hypertens,2008

3. The natriuretic peptides;Baxter;Basic Res Cardiol,2004

4. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions;Potter;Endocr Rev,2006

5. Identification of protease 3.4.24.11 as the major atrial natriuretic factor degrading enzyme in the rat kidney;Sonnenberg;Peptides,1988

Cited by 439 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kidney Outcomes Following Angiotensin Receptor-Neprilysin Inhibitor vs Angiotensin-Converting Enzyme Inhibitor/Angiotensin Receptor Blocker Therapy for Thrombotic Microangiopathy;JAMA Network Open;2024-09-12

2. LCZ696, an Angiotensin Receptor-Neprilysin Inhibitor, Ameliorates Endothelial Dysfunction in Diabetic C57BL/6 Mice;Journal of Atherosclerosis and Thrombosis;2024-09-01

3. Effect of ARNI (Sacubitril/Valsartan) and SGLT2 Inhibitors (Dapagliflozin) either alone or in Combination on Heart Failure: An Exploration of Novelty;Journal of Young Pharmacists;2024-08-23

4. Sacubitril/Valsartan Versus Enalapril in Chronic Chagas Cardiomyopathy;JACC: Heart Failure;2024-08

5. Inibidores da Neprilisina: Histórico, Farmacologia, Evidência Farmacológico-clínica e Prática Clínica, do Risco de Angioedema ao Pilar Terapêutico na Insuficiência Cardíaca;ABC Heart Failure & Cardiomyopathy;2024-07-11